FDA approves nuclear medicine PET software from Claritas NucMed

New PET Imaging Analysis Software iPETcertum Gains FDA Clearance

Claritas NucMed Technologies, a subsidiary of Claritas HealthTech, has announced that its latest software for PET imaging analysis, iPETcertum, has received clearance from the U.S. Food and Drug Administration (FDA). This new software is set to revolutionize the clinical landscape by enhancing PET images, automating segmentation and quantification, and improving efficiency in various clinical settings.

iPETcertum's vendor-neutral nature means it can work with all types of radionuclides, expanding its potential application in diverse clinical settings. This versatility is particularly beneficial in situations where isotope dose or scan times are reduced, as iPETcertum can help produce reliable diagnostic images from noisy scans.

One of the standout features of iPETcertum is its ability to automate the process of segmentation and quantification in PET imaging. This automation not only improves efficiency but also ensures consistency in analysis, potentially leading to more accurate diagnoses.

Clinicians working with noisy scans will find iPETcertum's image enhancement capabilities particularly useful. By improving visibility in PET scans, the software removes noise, making it easier for clinicians to assess standardized uptake values (SUV) and volumes from PET, PET/CT, or PET/MRI scans.

The display of segmentation regions in iPETcertum is customizable based on clinician-defined parameters, offering personalized analysis options. Clinicians can easily click on regions of interest (tumors/lesions) in PET scans for faster and more efficient analysis.

With iPETcertum, the time-consuming manual process of assessing SUV and volumes can be significantly reduced. This reduction in time spent on analysis allows clinicians to focus more on patient care and interpretation of results.

In summary, iPETcertum is a groundbreaking software that promises to improve the diagnostic quality of PET scans, automate segmentation and quantification, and increase efficiency in clinical settings. Its vendor-neutral nature, image enhancement capabilities, and customizable display of segmentation regions make it a valuable tool for clinicians working with PET imaging.